Cargando…
Tacrolimus or infliximab for severe ulcerative colitis: short-term and long-term data from a retrospective observational study
OBJECTIVE: Treatment of severe ulcerative colitis (UC) is challenging. Although the efficacy of tacrolimus (TAC) and infliximab (IFX) have been evaluated in patients with severe UC, the safety and efficacy levels of sequential therapies (TAC→IFX/IFX→TAC) in these patients remain unclear. The aim of...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599165/ https://www.ncbi.nlm.nih.gov/pubmed/26462273 http://dx.doi.org/10.1136/bmjgast-2014-000021 |